Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea
Yasuhiro Yabushita,Joon Seong Park,Yoo‐Seok Yoon,Masayuki Ohtsuka,Wooil Kwon,Gi Hong Choi,Masafumi Imamura,Ippei Matsumoto,Shugo Mizuno,Ryusei Matsuyama,Jun Sakata,Hiromitsu Hayashi,Yutaka Takeda,Satoshi Katagiri,Toshitaka Sugawara,Shogo Kobayashi,Yota Kawasaki,Hiroaki Nagano,Katsutoshi Murase,Hyung Sun Kim,Yang Won Nah,Jin‐Young Jang,Hiroki Yamaue,Dong Sup Yoon,Masakazu Yamamoto,Dongho Choi,Masafumi Nakamura,Ki‐Hun Kim,Itaru Endo
DOI: https://doi.org/10.1002/jhbp.1437
2024-06-01
Journal of Hepato-Biliary-Pancreatic Sciences
Abstract:Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract cancer. This study aimed to evaluate the efficacy and safety of conversion surgery in patients with initially unresectable locally advanced biliary tract cancer. Methods We retrospectively collected clinical data from groups of patients in multiple centers belonging to the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and Korean Association of Hepato‐Biliary‐Pancreatic Surgery. We analyzed two groups of prognostic factors (pretreatment and surgical factors) and their relation to the treatment outcomes. Results A total of 56 patients with initially unresectable locally advanced biliary tract cancer were enrolled in this study of which 55 (98.2%) patients received chemotherapy, and 16 (28.6%) patients received additional radiation therapy. The median time from the start of the initial treatment to resection was 6.4 months. Severe postoperative complications of Clavien‐Dindo grade III or higher occurred in 34 patients (60.7%), and postoperative mortality occurred in five patients (8.9%). Postoperative histological results revealed CR in eight patients (14.3%). The median survival time from the start of the initial treatment in all 56 patients who underwent conversion surgery was 37.7 months, the 3‐year survival rate was 53.9%, and the 5‐year survival rate was 39.1%. Conclusions Conversion surgery for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. However, more precise preoperative safety evaluation and careful postoperative management are required.
gastroenterology & hepatology,surgery